{
  "Abdallah 2016": {
    "key": "Abdallah 2016",
    "full": "Abdallah, C. G., Averill, L. A., Krystal, J. H., et al. (2016). Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology, 42(6), 1210–1219.",
    "authors": "Abdallah et al.",
    "year": "2016",
    "title": "Ketamine treatment and global brain connectivity in major depression",
    "journal": "Neuropsychopharmacology"
  },
  "Autry 2011": {
    "key": "Autry 2011",
    "full": "Autry, A. E., Adachi, M., Monteggia, L. M., et al. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses via spontaneous firing in the hippocampus. Nature, 475(7354), 91–95.",
    "authors": "Autry et al.",
    "year": "2011",
    "title": "NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses via spontaneous firing in the hippocampus",
    "journal": "Nature"
  },
  "Berman 2000": {
    "key": "Berman 2000",
    "full": "Berman, R. M., Cappiello, A., Anand, A., et al. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351–354.",
    "authors": "Berman et al.",
    "year": "2000",
    "title": "Antidepressant effects of ketamine in depressed patients",
    "journal": "Biological Psychiatry"
  },
  "Daly 2019": {
    "key": "Daly 2019",
    "full": "Daly, E. J., Singh, J. B., Fedgchin, M., et al. (2019). Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry, 75(2), 139–148.",
    "authors": "Daly et al.",
    "year": "2019",
    "title": "Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression",
    "journal": "JAMA Psychiatry"
  },
  "Domino 2010": {
    "key": "Domino 2010",
    "full": "Domino, E. F. (2010). Taming the ketamine tiger. Anesthesiology, 113(3), 678–684.",
    "authors": "Domino",
    "year": "2010",
    "title": "Taming the ketamine tiger",
    "journal": "Anesthesiology"
  },
  "Dore 2019": {
    "key": "Dore 2019",
    "full": "Dore, J., Turnipseed, B., Dwyer, S., et al. (2019). Ketamine-assisted psychotherapy for PTSD: A systematic review. Journal of Psychoactive Drugs, 51(2), 165–174.",
    "authors": "Dore et al.",
    "year": "2019",
    "title": "Ketamine-assisted psychotherapy for PTSD: A systematic review",
    "journal": "Journal of Psychoactive Drugs"
  },
  "Duman 2012": {
    "key": "Duman 2012",
    "full": "Duman, R. S., & Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. Science, 338(6103), 68–72.",
    "authors": "Duman & Aghajanian",
    "year": "2012",
    "title": "Synaptic dysfunction in depression: Potential therapeutic targets",
    "journal": "Science"
  },
  "Duman 2019": {
    "key": "Duman 2019",
    "full": "Duman, R. S., Shinohara, R., Fogaça, M. V., et al. (2019). Neurobiology of rapid-acting antidepressants: Evidence and implications. Nature Reviews Neuroscience, 20, 47–59.",
    "authors": "Duman et al.",
    "year": "2019",
    "title": "Neurobiology of rapid-acting antidepressants: Evidence and implications",
    "journal": "Nature Reviews Neuroscience"
  },
  "Feder 2014": {
    "key": "Feder 2014",
    "full": "Feder, A., Parides, M. K., Murrough, J. W., et al. (2014). Efficacy of intravenous ketamine for treatment of chronic PTSD: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688.",
    "authors": "Feder et al.",
    "year": "2014",
    "title": "Efficacy of intravenous ketamine for treatment of chronic PTSD: A randomized clinical trial",
    "journal": "JAMA Psychiatry"
  },
  "Krystal 1994": {
    "key": "Krystal 1994",
    "full": "Krystal, J. H., Karper, L. P., Seibyl, J. P., et al. (1994). Subanesthetic effects of ketamine in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51(3), 199–214.",
    "authors": "Krystal et al.",
    "year": "1994",
    "title": "Subanesthetic effects of ketamine in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses",
    "journal": "Archives of General Psychiatry"
  },
  "Li 2010": {
    "key": "Li 2010",
    "full": "Li, N., Lee, B., Liu, R. J., et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329(5994), 959–964.",
    "authors": "Li et al.",
    "year": "2010",
    "title": "mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists",
    "journal": "Science"
  },
  "Luckenbaugh 2014": {
    "key": "Luckenbaugh 2014",
    "full": "Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., et al. (2014). Do the dissociative side effects of ketamine mediate its antidepressant effects? Journal of Affective Disorders, 159, 56–61.",
    "authors": "Luckenbaugh et al.",
    "year": "2014",
    "title": "Do the dissociative side effects of ketamine mediate its antidepressant effects?",
    "journal": "Journal of Affective Disorders"
  },
  "Morgan 2012": {
    "key": "Morgan 2012",
    "full": "Morgan, C. J. A., & Curran, H. V. (2012). Ketamine use: A review. Addiction, 107(1), 27–38.",
    "authors": "Morgan & Curran",
    "year": "2012",
    "title": "Ketamine use: A review",
    "journal": "Addiction"
  },
  "Phillips 2019": {
    "key": "Phillips 2019",
    "full": "Phillips, J. L., Norris, S., Talbot, J., et al. (2019). Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Journal of Affective Disorders, 246, 527–535.",
    "authors": "Phillips et al.",
    "year": "2019",
    "title": "Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression",
    "journal": "Journal of Affective Disorders"
  },
  "Zanos 2018": {
    "key": "Zanos 2018",
    "full": "Zanos, P., & Gould, T. D. (2018). Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry, 23(4), 801–811.",
    "authors": "Zanos & Gould",
    "year": "2018",
    "title": "Mechanisms of ketamine action as an antidepressant",
    "journal": "Molecular Psychiatry"
  },
  "Zarate 2006": {
    "key": "Zarate 2006",
    "full": "Zarate, C. A., Singh, J. B., Carlson, P. J., et al. (2006). A randomized trial of an NMDA antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856–864.",
    "authors": "Zarate et al.",
    "year": "2006",
    "title": "A randomized trial of an NMDA antagonist in treatment-resistant major depression",
    "journal": "Archives of General Psychiatry"
  }
}
